Lilly's weight-loss pill wins US approval, sets up next battle with rival Novo Nordisk - Reuters

Chronological Source Flow
Back

AI Fusion Summary

Eli Lilly's GLP‑1 pill, Foundayo, has received FDA approval as the second obesity medication in pill form, competing with Novo Nordisk's Wegovy pill, marking a new option for weight management.
01/04 21:36 google.com
11 Πηγές
01/04 21:54 theguardian.com
01/04 21:56 wired.com
01/04 22:20 abc7ny.com
01/04 22:34 pbs.org
01/04 23:13 thehill.com
01/04 23:53 time.com
01/04 23:58 inc.com
02/04 00:02 bloomberg.com
02/04 00:34 adn.com
Comments
Loading...
0